[go: up one dir, main page]

TR200002921T2 - Yarı-Sentetik ekteinasidinler - Google Patents

Yarı-Sentetik ekteinasidinler

Info

Publication number
TR200002921T2
TR200002921T2 TR2000/02921T TR200002921T TR200002921T2 TR 200002921 T2 TR200002921 T2 TR 200002921T2 TR 2000/02921 T TR2000/02921 T TR 2000/02921T TR 200002921 T TR200002921 T TR 200002921T TR 200002921 T2 TR200002921 T2 TR 200002921T2
Authority
TR
Turkey
Prior art keywords
synthetic
semi
ekteinacids
acidacid
boc
Prior art date
Application number
TR2000/02921T
Other languages
English (en)
Inventor
Lloyd Rinehart Kenneth
J Morales Jose
Original Assignee
The Board Of Trustees Of The University Of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The University Of Illinois filed Critical The Board Of Trustees Of The University Of Illinois
Publication of TR200002921T2 publication Critical patent/TR200002921T2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Dental Preparations (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Furan Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Bu bulus, burada Et 757,Boc-Et 729, Iso-Et 743,Et875, ve Et 1560 olarak belirlenen birkaç yeni hazirlanmis yari-sentetik ekteinasidin (Et) türüyle ilgilidir. Bu bilesimlerin fiziksel özellikleri, hazirlanmalari ve biyo-aktiviteleri de açiklanmistir.
TR2000/02921T 1998-04-06 1999-04-05 Yarı-Sentetik ekteinasidinler TR200002921T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8080298P 1998-04-06 1998-04-06

Publications (1)

Publication Number Publication Date
TR200002921T2 true TR200002921T2 (tr) 2001-02-21

Family

ID=22159716

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02921T TR200002921T2 (tr) 1998-04-06 1999-04-05 Yarı-Sentetik ekteinasidinler

Country Status (27)

Country Link
US (1) US6124293A (tr)
EP (2) EP1067933B1 (tr)
JP (1) JP4443043B2 (tr)
KR (1) KR100603219B1 (tr)
CN (1) CN1157189C (tr)
AT (1) ATE370148T1 (tr)
AU (1) AU758100B2 (tr)
BG (1) BG65088B1 (tr)
BR (1) BR9909488B1 (tr)
CA (1) CA2327468C (tr)
CY (1) CY1106988T1 (tr)
CZ (1) CZ301083B6 (tr)
DE (1) DE69936845T2 (tr)
DK (1) DK1067933T3 (tr)
ES (1) ES2292237T3 (tr)
HU (1) HUP0104273A3 (tr)
IL (2) IL138856A0 (tr)
MX (1) MXPA00009840A (tr)
NO (1) NO328147B1 (tr)
NZ (1) NZ507350A (tr)
PL (1) PL196809B1 (tr)
PT (1) PT1067933E (tr)
RU (1) RU2217432C2 (tr)
SK (1) SK285669B6 (tr)
TR (1) TR200002921T2 (tr)
UA (1) UA59439C2 (tr)
WO (1) WO1999051238A1 (tr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
SK285069B6 (sk) * 1998-05-11 2006-05-04 Pharma Mar, S. A. Zlúčeniny, ktoré sú metabolitmi ekteinascidínu 743, farmaceutické prostriedky s ich obsahom a ich použitie
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
MY130271A (en) * 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
WO2001053299A1 (en) 2000-01-19 2001-07-26 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US6809099B2 (en) 2000-11-03 2004-10-26 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
BR0115162A (pt) * 2000-11-06 2003-10-21 Pharma Mar Sa Tratamentos antitumorais eficazes
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
US7622458B2 (en) * 2003-11-13 2009-11-24 Pharma Mar, S.A.U. Combination of ET-743 and a 5-fluorouracil pro-drug for cancer treatment
CA2545054A1 (en) * 2003-11-14 2005-06-02 Pharma Mar, S.A. Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
CA2573072A1 (en) * 2004-07-09 2006-01-19 Rafael Rosell Costa Use of ecteinascidin in the treatment of cancer in patients with low level of brca1
JP2008514688A (ja) * 2004-09-29 2008-05-08 ファルマ・マル・エス・アー, ソシエダッド・ユニペルソナル 抗炎症剤としてのエクテイナシジン化合物
NZ554765A (en) * 2004-10-26 2010-01-29 Pharma Mar Sa Pegylated Liposomal Doxorubicin In Combination With Ecteinescidin 743
DK1658848T3 (da) 2004-10-29 2007-11-26 Pharma Mar Sa Formuleringer omfattende ecteinascidin og et disaccharid
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CN100355775C (zh) * 2006-01-20 2007-12-19 南方医科大学 一种海鞘多肽及其制备方法
JP2011500046A (ja) * 2007-10-19 2011-01-06 ファルマ・マール・ソシエダード・アノニマ Et−743治療のための予後分子マーカー
TR201904459T4 (tr) 2010-11-12 2019-05-21 Pharma Mar Sa Bir mitotik inhibitör ile kombinasyon terapisi.
CN107427512B (zh) * 2016-02-04 2021-10-08 江苏恒瑞医药股份有限公司 一种曲贝替定的可注射胃肠外用药物组合物及其制备方法
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
IL293128A (en) 2019-11-21 2022-07-01 Pharma Mar Sa Methods of treating small cell lung cancer with lurbinectedin formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
TW221441B (tr) * 1991-01-25 1994-03-01 Taiho Pharmaceutical Co Ltd
US5440055A (en) * 1993-03-12 1995-08-08 Aphios Corporation Method and apparatus for extracting taxol from source materials
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds

Also Published As

Publication number Publication date
NZ507350A (en) 2003-03-28
RU2217432C2 (ru) 2003-11-27
DK1067933T3 (da) 2007-12-27
PT1067933E (pt) 2007-11-15
KR100603219B1 (ko) 2006-07-20
ATE370148T1 (de) 2007-09-15
NO20004978D0 (no) 2000-10-03
IL138856A (en) 2007-07-24
PL343439A1 (en) 2001-08-13
HK1033651A1 (en) 2001-09-14
DE69936845T2 (de) 2008-05-08
NO20004978L (no) 2000-12-05
SK285669B6 (sk) 2007-06-07
EP1876180A3 (en) 2009-12-16
JP4443043B2 (ja) 2010-03-31
NO328147B1 (no) 2009-12-21
KR20010074474A (ko) 2001-08-04
HUP0104273A3 (en) 2003-12-29
BG65088B1 (bg) 2007-02-28
CY1106988T1 (el) 2012-09-26
CN1157189C (zh) 2004-07-14
SK15012000A3 (sk) 2001-08-06
CA2327468C (en) 2008-05-06
WO1999051238A1 (en) 1999-10-14
PL196809B1 (pl) 2008-02-29
EP1876180A2 (en) 2008-01-09
EP1067933B1 (en) 2007-08-15
CZ301083B6 (cs) 2009-11-04
EP1067933A4 (en) 2002-12-18
HUP0104273A2 (hu) 2002-03-28
RU2000128058A (ru) 2004-02-20
UA59439C2 (uk) 2003-09-15
AU758100B2 (en) 2003-03-13
ES2292237T3 (es) 2008-03-01
WO1999051238A9 (en) 2000-01-27
BR9909488B1 (pt) 2011-02-08
CZ20003650A3 (en) 2001-06-13
IL138856A0 (en) 2001-10-31
BG104902A (en) 2001-07-31
AU3471399A (en) 1999-10-25
MXPA00009840A (es) 2002-04-24
US6124293A (en) 2000-09-26
DE69936845D1 (de) 2007-09-27
CN1304309A (zh) 2001-07-18
EP1067933A1 (en) 2001-01-17
CA2327468A1 (en) 1999-10-14
BR9909488A (pt) 2000-12-26
JP2002510633A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
TR200002921T2 (tr) Yarı-Sentetik ekteinasidinler
FI914928L (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
DE69112290D1 (de) Verspritzbare, feuerfeste Zusammensetzung.
ID23374A (id) Halogenopirimidin
DE3582953D1 (de) Faserhaltige, teilchenfoermige elastomerzusammensetzung.
DE69005438D1 (de) Bernsteinsäureimid-Zusammensetzungen.
DE3585294D1 (de) Molekularsiebzusammensetzungen.
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
FI931427A0 (fi) Ny onkofetal gen, genprodukt och anvaendningen daerav
DE3775170D1 (de) Trockenes abziehbild, dessen unerwuenschte flaechen sich selbststaendig von den bildflaechen trennen.
DE3584905D1 (de) Molekularsiebzusammensetzungen.
FI923536A0 (fi) Foerfarande foer analysering av gasprov, analyseringsanordning, dess anvaendning och en test anlaeggning med den naemnda analyseringsanordningen.
DE69016390D1 (de) Nitrierofen.
DE69715038D1 (de) Auf (n-phenylacetyl-n-2,6-xylyl)methylalaninat basierte fungizide zusammensetzungen
FI875703A7 (fi) Lääkelaastarikoostumuksia.
DE69020842D1 (de) Organosilikonzusammensetzungen.
DE69020121D1 (de) Gasbetriebenes Kochfeld.
DE3576488D1 (de) Molekularsieb-zusammensetzungen.
DE69003075D1 (de) Stabilisierungszusammensetzungen.
DE69014859D1 (de) Spleissverschlüsse.
FR2707297B1 (fr) Mélange silicone autoémulsifiable.
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
TR199900403T2 (tr) Amorf benzotiofenler, hazirlama yöntemleri ve kullanma yöntemleri.
IL139604A0 (en) Novel peptides
FI904997A7 (fi) Foerfarande foer bestaemning av ingrediensinhalter av gas.